Skip to main content

Pitt-Hopkins Syndrome clinical trials at UCSF

1 research study open to eligible people

Showing trials for
  • Oral NNZ-2591 in Pitt Hopkins Syndrome (PTHS-001)

    open to eligible people ages 3-17

    A study of the safety, tolerability and pharmacokinetics of NNZ-2591 and measures of efficacy in children and adolescents with Pitt Hopkins Syndrome.

    San Francisco, California and other locations

Last updated: